Dee Ann Omatsu
Pediatrics · Honolulu, HINPI 1851523211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $112.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Jazz Pharmaceuticals Inc.$817
- E.r. Squibb & Sons, L.L.C.$643
- Johnson & Johnson$522
- Servier Pharmaceuticals LLC$512
- Daiichi Sankyo Inc.$506
- plus $4K from 23 others
What the payments were for
- Food & beverage$7,38092%
- Education$6408%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $1,218 |
| Jazz Pharmaceuticals Inc. | 7 | $817 |
| E.r. Squibb & Sons, L.L.C. | 5 | $643 |
| Johnson & Johnson | 4 | $522 |
| Servier Pharmaceuticals LLC | 4 | $512 |
| Daiichi Sankyo Inc. | 4 | $506 |
| Incyte Corporation | 4 | $445 |
| EMD Serono, Inc. | 4 | $406 |
| GSK | 4 | $370 |
| Seagen Inc. | 3 | $277 |
| Sanofi | 2 | $260 |
| Merck | 2 | $206 |
| Amgen | 2 | $171 |
| Syndax Pharmaceuticals, Inc. | 1 | $150 |
| Sobi, Inc | 1 | $150 |
| AbbVie | 1 | $125 |
| Exelixis Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Kyowa Kirin, Inc. | 1 | $125 |
| BTG International Inc. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $123 |
| Karyopharm Therapeutics Inc. | 1 | $123 |
| Pharmaessentia USA Corporation | 1 | $122 |
| Deciphera Pharmaceuticals Inc. | 1 | $119 |
| Springworks Therapeutics, Inc. | 1 | $100 |
| Genentech, Inc. | 1 | $94 |
| Pfizer | 1 | $30 |
| Teleflex LLC | 1 | $20 |
| Acrotech Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,019 in reported general payments places this provider in the 95th percentile of 208 pediatrics providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatrics in Honolulu
- Anne JinboHonolulu$8K
- Gregory YimHonolulu$3K
- Daniel BuehlerHonolulu$2K
- Shellie UsamiHonolulu$2K
- Asad GhiasuddinHonolulu$1K
- Erika PearsonHonolulu$1K
- Cherise SaitoHonolulu$1K
- Lulumafuie FiatoaHonolulu$1K
- Jasmine WaipaHonolulu$1K
- Vince YamashiroyaHonolulu$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.